Discussion in 'Fibromyalgia Main Forum' started by simpsons, Oct 29, 2009.

  1. simpsons

    simpsons Member

    Warning from WPI on this test below, seemingly they put this on their Facebook page last night:

    "The WPI knows nothing of this test and does not recommend it's use or Lab . We will be contacting CRL Lab as well as Cooperative Diagnostics and addressing this on our main website"

    Here is the press release on this test from Cooperative Diagnostics, sorry it is printing out in a weird way, probably best to read on the link:


    Cooperative Diagnostics Launches New Diagnostic Test for Chronic Fatigue
    Syndrome Associated Virus
    Greenwood, SC, Oct 24th, 2009 – Cooperative Diagnostics, LLC announced today the availability of a new
    diagnostic assay for Xenotropic Murine Leukemia-Related Virus (XMRV) to assist physicians in the diagnosis
    of Chronic Fatigue Syndrome and other disorders potentially caused by the virus. Testing services will also
    be made available to the general public.
    The Simplex XMRV test identifies patients infected with XMRV. XMRV has been recently identified in 95% of
    Chronic Fatigue Syndrome patients, in addition to large numbers of patients with Fibromyalgia, Atypical
    Multiple Sclerosis, and other clinical conditions. Cooperative Diagnostic's XMRV assay is the first diagnostic
    for the virus to be made available to the public.
    "This may well be the fulfillment of a promise that I made a number of years ago to two good friends, who
    both became ill from Chronic Fatigue Syndrome. I saw firsthand the mental anguish they endured by those
    closest to them including the medical community as they were told their condition could be psychological,"
    said Brent C. Satterfield, Ph.D., President and CEO of Cooperative Diagnostics, LLC. "When we learned that
    XMRV might have such a high association with Chronic Fatigue Syndrome, we immediately became
    interested in developing a test. Now, my two friends and everyone else who has suffered from the
    condition can take testing for XMRV into their own hands."
    The Cooperative Diagnostics XMRV test is based on its proprietary real-time PCR nucleic acid detection
    technologies. It is capable of detecting the virus inside of blood cells. The test is available to the public at
    www.codiagnostics.com/XMRV/index.php for $399.00. In order to provide quality testing in a high
    throughput environment, Cooperative Diagnostics has contracted Clinical Reference Laboratory, Inc. (CRL),
    to process these assays.
    CRL's Executive Director of Molecular Diagnostics, Dr. Heather Newkirk, said "this unique technology from
    Cooperative Diagnostics enables a powerful detection product which synergizes well with CRL's expertise in
    offering quality molecular services. We look forward to working with Cooperative Diagnostics to provide
    quality services."
    About Cooperative Diagnostics, LLC
    Cooperative Diagnostics, founded in January 2008, brings the most advanced molecular diagnostics to the
    people and nations that need them most. For more information visit www.codiagnostics.com
    About Clinical Reference Laboratory, Inc.
    Established in 1979, CRL is a privately held reference laboratory in Lenexa, Kansas offering leading-edge
    testing services in the areas of Clinical Trials, Molecular Diagnostics, Insurance, and Toxicology. CRL is one
    of the largest singlesite laboratories in the country and analyzes over 80 million tests annually. Additional
    information is available at www.crlcorp.com
    SOURCE Cooperative Diagnostics, LLC

  2. UsedtobePerkyTina

    UsedtobePerkyTina New Member

    I hate to see the infighting.

    But at the same time, I like seeing anyone and everyone wanting to get involved, even if it is for profit motive. Eventually, Pfizer or someone like that will get involved. It will be a groundswell up instead of a trickle down.

    When these small clinics, labs, whatever market something that people are buying, then bigger companies will want in on the action.